Treatment Recommendation for Group B Streptococcus Wound Infection in a Penicillin-Allergic Patient
Use a first-generation cephalosporin (cefazolin) as your first-line treatment for this Group B Streptococcus wound infection, given that the patient is not allergic to cephalosporins.
Rationale for Cephalosporin Use
Since your patient tolerates cephalosporins, you have an excellent treatment option. The 2022 Drug Allergy Practice Parameter clearly states that patients with penicillin allergy history can safely receive cephalosporins, with cross-reactivity rates being extremely low at <5% 1. Even more reassuring, the linked probability of a reaction in patients with unverified penicillin allergy receiving cephalosporins is approximately 0.1% 1.
For this specific clinical scenario, cefazolin (1-2 g IV every 8 hours) is the optimal choice because:
- All Group B Streptococcus isolates in multiple studies remained universally susceptible to first-generation cephalosporins 2
- Cefazolin is the most frequently used antibiotic for GBS prophylaxis in penicillin-allergic patients 3
- The guideline explicitly states that cephalosporins can be administered without prior testing or additional precautions in penicillin-allergic patients 1
Why Not Other Alternatives?
Clindamycin is NOT an option
You've already stated the patient is allergic to clindamycin, so this is off the table. This is actually fortunate because clindamycin resistance in GBS has become alarmingly high:
- Resistance rates range from 17.5% to 40% in recent studies 4, 5, 6
- One study showed clindamycin resistance exceeding 20% by 2010 across most GBS serotypes 6
- The 2022 Korean study documented a persistent 40% clindamycin resistance rate 5
Vancomycin should be avoided
While vancomycin maintains 100% susceptibility against GBS 7, 2, using it here represents overtreatment 8. Reserve vancomycin for patients who cannot receive any beta-lactam antibiotics or when MRSA coverage is needed for polymicrobial infections 9.
Fluoroquinolones are suboptimal
The IDSA guidelines mention fluoroquinolones primarily for polymicrobial necrotizing infections 9, not simple GBS wound infections. They lack the targeted activity you need here.
Treatment Duration and Monitoring
Based on the IDSA skin and soft tissue infection guidelines 9:
- Administer antibiotics intravenously initially
- Once clinical improvement occurs, transition to oral cephalexin (500 mg four times daily)
- Continue treatment for 2-3 weeks total
- Monitor for treatment failure, which would prompt wound culture and susceptibility testing
Important Clinical Pearls
Penicillin allergy verification: If time permits and resources allow, consider that most reported penicillin allergies are not true allergies. However, given your patient's multiple drug allergies (penicillin, Augmentin, sulfa, clindamycin), proceeding directly with cefazolin is both safe and appropriate 1.
Antibiotic susceptibility testing: While all GBS isolates remain penicillin-susceptible 6, and cephalosporin resistance is essentially non-existent, obtaining wound cultures is still good practice for any wound infection to confirm the pathogen and guide therapy if clinical response is inadequate 9.
Common pitfall to avoid: Do not reflexively reach for vancomycin just because the patient has multiple antibiotic allergies. The evidence strongly supports cephalosporin safety in this population, and vancomycin overuse contributes to resistance patterns 8.